BioCentury | Mar 23, 2018
Strategy

Arbiter of value

...is more focused on budget,”said Jack Mycka, global president and CEO of market access consultancy Medical Marketing Economics LLC...
BioCentury | Feb 24, 2018
Strategy

Patients as pawns

...level II rating. According to Jack Mycka, global president & CEO at market access consultancy Medical Marketing Economics LLC...
BioCentury | Apr 15, 2017
Strategy

WAC-a-mol

...use later on fairly easily,” said Jack Mycka, global president and CEO of reimbursement consultancy Medical Marketing Economics LLC...
...Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Institute for Clinical and Economic Review, Boston, Mass. Medical Marketing Economics LLC...
BioCentury | Feb 4, 2017
Strategy

Lawyers, drugs and money

...the market doesn’t fix that,” said Jack Mycka, global president and CEO at reimbursement consultancy Medical Marketing Economics LLC...
...Ann Arbor, Mich. Harvard Pilgrim Health Care Inc., Boston, Mass Massachusetts General Hospital, Boston, Mass. Medical Marketing Economics LLC...
BioCentury | Dec 8, 2014
Strategy

Pricing gene therapies

...performance over time," she told BioCentury. Jack Mycka, global president and CEO of healthcare consultancy Medical Marketing Economics LLC...
...Quality and Efficiency in Healthcare (IQWiG), Berlin, Germany Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Medical Marketing Economics LLC...
BioCentury | Jun 16, 2014
Company News

Chimera Biotec, Kineta, KPI Therapeutics, Life Chemicals, Medical Marketing Economics, MPI Research, Seattle Children's Research Institute autoimmune news

...Seattle, Wash. KPI Therapeutics Inc. , Seattle, Wash. Life Chemicals Inc. , Niagara-on-the-Lake, Ontario Medical Marketing Economics LLC...
Items per page:
1 - 6 of 6
BioCentury | Mar 23, 2018
Strategy

Arbiter of value

...is more focused on budget,”said Jack Mycka, global president and CEO of market access consultancy Medical Marketing Economics LLC...
BioCentury | Feb 24, 2018
Strategy

Patients as pawns

...level II rating. According to Jack Mycka, global president & CEO at market access consultancy Medical Marketing Economics LLC...
BioCentury | Apr 15, 2017
Strategy

WAC-a-mol

...use later on fairly easily,” said Jack Mycka, global president and CEO of reimbursement consultancy Medical Marketing Economics LLC...
...Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Institute for Clinical and Economic Review, Boston, Mass. Medical Marketing Economics LLC...
BioCentury | Feb 4, 2017
Strategy

Lawyers, drugs and money

...the market doesn’t fix that,” said Jack Mycka, global president and CEO at reimbursement consultancy Medical Marketing Economics LLC...
...Ann Arbor, Mich. Harvard Pilgrim Health Care Inc., Boston, Mass Massachusetts General Hospital, Boston, Mass. Medical Marketing Economics LLC...
BioCentury | Dec 8, 2014
Strategy

Pricing gene therapies

...performance over time," she told BioCentury. Jack Mycka, global president and CEO of healthcare consultancy Medical Marketing Economics LLC...
...Quality and Efficiency in Healthcare (IQWiG), Berlin, Germany Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Medical Marketing Economics LLC...
BioCentury | Jun 16, 2014
Company News

Chimera Biotec, Kineta, KPI Therapeutics, Life Chemicals, Medical Marketing Economics, MPI Research, Seattle Children's Research Institute autoimmune news

...Seattle, Wash. KPI Therapeutics Inc. , Seattle, Wash. Life Chemicals Inc. , Niagara-on-the-Lake, Ontario Medical Marketing Economics LLC...
Items per page:
1 - 6 of 6